TP53 and cancer: Cancer cells could become resistant to cisplatin through multiple mechanisms, which include an increase in the drug export, upregulation of DNA repair capacity, inactivation of the p53-mediated apoptotic response to DNA damage, and aberrant cell cycle regulation [25].